Laser beam aims to turn back the clock on sagging skin
NCT ID NCT07759817
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This trial tests whether a special laser, called UltraClear, can safely improve skin laxity and provide a lifting effect on the lower face, under the chin, and neck. Up to 50 adults aged 35 to 65 will receive two laser treatments about seven weeks apart. Researchers will check results about three months after the second treatment using photos and ratings from both doctors and participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- UltraClear® 2,910 nm fractional ablative fiber laser (a device that uses laser energy to resurface and tighten skin)
- What this could lead to
- If successful, this could establish a non-surgical option for tightening and lifting loose skin on the lower face and neck, potentially reducing the need for invasive procedures.
- What could go wrong
- This is a small, early-stage study (50 people) without a control group, so results may not be conclusive. Laser treatments can cause temporary redness, swelling, or pigment changes, and the effect may vary between individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN LAXITY (SUBMENTAL AND NECK) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Dermatology & Laser Surgery Center
Houston, Texas, 77004, United States
Contact Email: •••••@•••••
-
Julene B Samuels MD, FACS
Prospect, Kentucky, 40059, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.